SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001193125-09-162430
Filing Date
2009-08-04
Accepted
2009-08-03 18:17:31
Documents
5
Period of Report
2009-06-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q d10q.htm 10-Q 626454
2 SECTION 302 CEO CERTIFICATION dex311.htm EX-31.1 9353
3 SECTION 302 CFO CERTIFICATION dex312.htm EX-31.2 9356
4 SECTION 906 CEO CERTIFICATION dex321.htm EX-32.1 3669
5 SECTION 906 CFO CERTIFICATION dex322.htm EX-32.2 3672
  Complete submission text file 0001193125-09-162430.txt   653921
Mailing Address 4222 EMPEROR BLVD STE 200 DURHAM NC 27703-8466
Business Address 4222 EMPEROR BLVD STE 200 DURHAM NC 27703-8466 9199419777
INSPIRE PHARMACEUTICALS INC (Filer) CIK: 0001040416 (see all company filings)

IRS No.: 043209022 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-31577 | Film No.: 09981274
SIC: 2834 Pharmaceutical Preparations